PREVALENCE OF THE METABOLIC SYNDROME IN DIABETIC PATIENTS LIVING IN A COASTAL REGION OF BANGLADESH
Metabolic syndrome (MetS) is a clustering of metabolic abnormalities that has close association with cardiovascular mortality. MetS has becoming a major challenge for public health. To get insight knowledge about the MetS in diabetes, this population-based study was designed. Here we assessed the Me...
Gespeichert in:
Veröffentlicht in: | International journal of pharmaceutical sciences and research 2012-08, Vol.3 (8), p.2633-2633 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Metabolic syndrome (MetS) is a clustering of metabolic abnormalities that has close association with cardiovascular mortality. MetS has becoming a major challenge for public health. To get insight knowledge about the MetS in diabetes, this population-based study was designed. Here we assessed the MetS in diabetes from a coastal region of Bangladesh. MetS was estimated by using the modified definition of the National Cholesterol Education Program Adult Treatment Panel III. A total of 500 patients visiting to a diabetic clinic were included in this study. Anthropometric, clinical and biochemical data were recorded. Our result revealed that, about 47.00% patients with type 2 diabetic mellitus were suffering from metabolic syndrome. Female were more prevalent than male (58.6% vs 36.14%) for suffering from MetS. Among other risk factors for MetS, obesity and hypertriglyceridemia followed by low-HDL were more prevalent in female. In contrast, male were more likely to have low-HDL and hypertriglyceridemia followed by high blood pressure. Since diabetic patients are more porn to suffer from MetS, and it becomes a major risk factor for cardiovascular disease, correct measurement should be taken to identify MetS among different population to reduce the high abnormalities. |
---|---|
ISSN: | 0975-8232 |
DOI: | 10.13040/IJPSR.0975-8232.3(8).2633-38 |